Salud materna indígena en mujeres Nasa y Misak del Cauca, Colombia: tensiones, subordinación y diálogo intercultural entre dos sistemas médicos

Resumen En este texto se pretende avanzar en la comprensión de los elementos que configuran la relación entre madres Nasa y Misak del Cauca y los servicios de salud materna tradicional y occidental, desde un abordaje cualitativo que armonizó el modelo de construcción de sentido y la teoría fundamentada. Se identificó la forma cómo cada sistema médico define la salud, la enfermedad y la maternidad, que está reflejada en las prácticas y cuidados, siendo el parto el momento de mayores tensiones. Se han identificado patrones de relacionamiento entre los dos agentes del sistema médico. El sistema médico tradicional con bajo desarrollo propio y pérdida progresiva de valores culturales, así como el sistema médico occidental con la ausencia de servicios de salud apropiados culturalmente, dejan a las madres en un espacio de incertidumbre en el que no es posible realizar las prácticas tradicionales, ni acceder a los servicios propuestos por el sistema médico occidental.This study sought to understand the components of the relationship between mothers from Nasa and Misak ethnicities from Cauca, Colombia, and both the indigenous and Western health care services for maternal health, through qualitative approach harmonizing the model of construction of meaning and grounded theory. Elements about health, illness and motherhood conceptualization inside each system were rescued. These elements are expressed in care practices, being the labor the moment of greatest tension. Patterns of relationships between actors of both medical systems were also identified. An indigenous health system with low development and progressive loss of values, in conjunction with a Western medical system without culturally appropriate health services, results in mothers in an environment of uncertainty where it is not possible to carry out traditional practices, nor having access to proper allopathic services

Experiencias departamentales en la construcción, divulgación y uso del análisis de situación de salud, Colombia 2016

Objetivo El Análisis de Situación de Salud (ASIS) es una metodología que se encuentra en implementación recientemente en Colombia. Este estudio buscó comprender la experiencia de construcción, divulgación y uso del ASIS para la toma de decisiones en  algunas entidades territoriales (ET).Métodos Entrevistas semiestructuradas a funcionarios de las entidades departamentales  de salud; la información fue analizada de acuerdo a un conjunto de categorías establecidas previamente.Resultados Las ET implementan el ASIS incorporando el enfoque de los Determinantes Sociales de la Salud; sin embargo, las capacidades técnicas, económicas y humanas son desiguales para la elaboración de este tipo de análisis; la participación intersectorial y social aún es débil y los resultados generados todavía no orientan latoma de decisiones a nivel territorial.Conclusiones La metodología ASIS aspira a posicionarse como uno de los mecanismos oficiales para generar evidencia que oriente las políticas y la toma de decisiones en salud a nivel nacional, regional y local; existen desafíos a nivel económico, institucional y político para su consolidación como estrategia de útil en la planificación en salud. El ASIS es una metodología de gran relevancia para las ET y debe seguir fortaleciéndose su implementación.Objetive The Health Situation Analysis (ASIS in Spanish) is a methodology that has been implemented recently in Colombia. This study aims at understanding the experience of building, disseminating and using ASIS for decision-making in some territorial entities.Methods Semistructured interviews were applied to officials of the departmental health entities. The information was analyzed according to a set of categories previously established.Results The territorial entities implement ASIS by incorporating the Social Determinants of Health approach; however, the technical, economic and human capacities for the elaboration of this type of analysis are not equitable. Intersectoral and social participation isstill weak and the results do not guide the decision making at territorial level yet.Conclusions The ASIS methodology seeks to position itself as one of the official mechanisms to generate evidence that guides health policy and decision making at national, regional and local levels. There are economic, institutional and political challenges forits consolidation as a useful strategy in health planning. ASIS is a methodology of great relevance for the territorial entities and its implementation should be further strengthened

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Salud materna indígena en mujeres Nasa y Misak del Cauca, Colombia: tensiones, subordinación y diálogo intercultural entre dos sistemas médicos

Resumen En este texto se pretende avanzar en la comprensión de los elementos que configuran la relación entre madres Nasa y Misak del Cauca y los servicios de salud materna tradicional y occidental, desde un abordaje cualitativo que armonizó el modelo de construcción de sentido y la teoría fundamentada. Se identificó la forma cómo cada sistema médico define la salud, la enfermedad y la maternidad, que está reflejada en las prácticas y cuidados, siendo el parto el momento de mayores tensiones. Se han identificado patrones de relacionamiento entre los dos agentes del sistema médico. El sistema médico tradicional con bajo desarrollo propio y pérdida progresiva de valores culturales, así como el sistema médico occidental con la ausencia de servicios de salud apropiados culturalmente, dejan a las madres en un espacio de incertidumbre en el que no es posible realizar las prácticas tradicionales, ni acceder a los servicios propuestos por el sistema médico occidental

Los saberes múltiples y las ciencias sociales y políticas

Este libro debe comprenderse como un intento de formalización por escrito de las razones y emociones que animaron el Coloquio Internacional sobre Saberes Múltiples, Ciencias Sociales y Políticas, realizado en la Sede Bogotá de la Universidad Nacional de Colombia (18-21 de octubre de 2016). Este evento contó con la colaboración de la Universidade Nova de Lisboa (CICS - Centro Interdisciplinar de Ciências Sociais), la Universität Freiburg (Suiza), la Unievrsidade Estadual de Montes Claros (Brasil), la Université catholique de Louvain (Bélgica) y la Association internationale des sociologues de langue française (AISLF) en el marco de las actividades del Comité de recherche 30 (CR30) (Inégalités, identités et liens sociaux). Los textos reunidos aquí son testimonios de los debates alrededor de dos perspectivas metodológicas y epistemológicas que con frecuencia se confrontan en el campo de las ciencias sociales y políticas: la monista y la pluralista. Los grandes temas que animaron las discusiones fueron: 1) los movimientos sociales o las sociedades y comunidades en movimiento; 2) los saberes sociales: indígenas, populares y ancestrales; 3) los estudios sobre el género y la diversidad sexual; 4) el ambientalismo, el ecologismo, los estudios sobre el territorio, el desarrollo y el animalismo; 5) la investigación acción participativa, la intervención sociológica y la educación popular; y 6) el debate epistemológico

Brazilian Flora 2020: Leveraging the power of a collaborative scientific network

International audienceThe shortage of reliable primary taxonomic data limits the description of biological taxa and the understanding of biodiversity patterns and processes, complicating biogeographical, ecological, and evolutionary studies. This deficit creates a significant taxonomic impediment to biodiversity research and conservation planning. The taxonomic impediment and the biodiversity crisis are widely recognized, highlighting the urgent need for reliable taxonomic data. Over the past decade, numerous countries worldwide have devoted considerable effort to Target 1 of the Global Strategy for Plant Conservation (GSPC), which called for the preparation of a working list of all known plant species by 2010 and an online world Flora by 2020. Brazil is a megadiverse country, home to more of the world's known plant species than any other country. Despite that, Flora Brasiliensis, concluded in 1906, was the last comprehensive treatment of the Brazilian flora. The lack of accurate estimates of the number of species of algae, fungi, and plants occurring in Brazil contributes to the prevailing taxonomic impediment and delays progress towards the GSPC targets. Over the past 12 years, a legion of taxonomists motivated to meet Target 1 of the GSPC, worked together to gather and integrate knowledge on the algal, plant, and fungal diversity of Brazil. Overall, a team of about 980 taxonomists joined efforts in a highly collaborative project that used cybertaxonomy to prepare an updated Flora of Brazil, showing the power of scientific collaboration to reach ambitious goals. This paper presents an overview of the Brazilian Flora 2020 and provides taxonomic and spatial updates on the algae, fungi, and plants found in one of the world's most biodiverse countries. We further identify collection gaps and summarize future goals that extend beyond 2020. Our results show that Brazil is home to 46,975 native species of algae, fungi, and plants, of which 19,669 are endemic to the country. The data compiled to date suggests that the Atlantic Rainforest might be the most diverse Brazilian domain for all plant groups except gymnosperms, which are most diverse in the Amazon. However, scientific knowledge of Brazilian diversity is still unequally distributed, with the Atlantic Rainforest and the Cerrado being the most intensively sampled and studied biomes in the country. In times of “scientific reductionism”, with botanical and mycological sciences suffering pervasive depreciation in recent decades, the first online Flora of Brazil 2020 significantly enhanced the quality and quantity of taxonomic data available for algae, fungi, and plants from Brazil. This project also made all the information freely available online, providing a firm foundation for future research and for the management, conservation, and sustainable use of the Brazilian funga and flora

Health-status outcomes with invasive or conservative care in coronary disease

BACKGROUND In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients. METHODS We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency. RESULTS At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina). CONCLUSIONS In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline

Initial invasive or conservative strategy for stable coronary disease

BACKGROUND Among patients with stable coronary disease and moderate or severe ischemia, whether clinical outcomes are better in those who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain. METHODS We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial conservative strategy of medical therapy alone and angiography if medical therapy failed. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. A key secondary outcome was death from cardiovascular causes or myocardial infarction. RESULTS Over a median of 3.2 years, 318 primary outcome events occurred in the invasive-strategy group and 352 occurred in the conservative-strategy group. At 6 months, the cumulative event rate was 5.3% in the invasive-strategy group and 3.4% in the conservative-strategy group (difference, 1.9 percentage points; 95% confidence interval [CI], 0.8 to 3.0); at 5 years, the cumulative event rate was 16.4% and 18.2%, respectively (difference, 121.8 percentage points; 95% CI, 124.7 to 1.0). Results were similar with respect to the key secondary outcome. The incidence of the primary outcome was sensitive to the definition of myocardial infarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical importance. There were 145 deaths in the invasive-strategy group and 144 deaths in the conservative-strategy group (hazard ratio, 1.05; 95% CI, 0.83 to 1.32). CONCLUSIONS Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years. The trial findings were sensitive to the definition of myocardial infarction that was used